ENTA
Enanta Pharmaceuticals, Inc.Closed11.52−0.78 −6.34%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 11.52 0.00%
Open
12.37
Prev close
12.30
Day range
11.3912.37
52-week range
10.2017.15
Volume
173.99K0.76×
Mkt cap
335.52M
P/E ttm
—
Fwd P/E
-4.85
EPS ttm
-2.42
Div yield
0.00%
Earnings
—
From 52w high
−32.83%
ENTA compared with peers
ENTA vs Peers
5 peers · related companies in the same sector
Forward P/E
−4.9×
peer median 17.1×
EV/EBITDA
−6.1×
peer median 28.1×
Price / sales
5.1×
peer median 12.8×· 60% discount
Net margin
−96.9%
peer median −3.8%· −93.1 pts
Revenue growth
−21.6%
peer median 101.5%· −123.1 pts
Comparison
| Company | Mkt cap | Today | Fwd P/E | P/E | PEG | P/S | P/B | EV/EBITDA | EV/Sales | Div yield | Remove |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTAEnanta Pharmaceuticals, Inc. | 335.52M | −6.3% | −4.9× | — | — | 5.1× | 3.3× | −6.1× | 5.0× | 0.0% | |
| PTCTPTC Therapeutics, Inc. | 5.00B | −4.8% | 25.3× | — | — | 5.0× | — | 33.8× | 5.7× | 0.0% | |
| AGIOAgios Pharmaceuticals, Inc. | 1.80B | −2.0% | −7.5× | — | — | 18.3× | 1.8× | −2.7× | 12.4× | 0.0% | |
| XNCRXencor, Inc. | 1.75B | −6.1% | −6.6× | — | — | 16.7× | 3.5× | −7.1× | 13.9× | 0.0% | |
| ANABAnaptysBio, Inc. | 1.36B | −1.0% | 9.0× | — | — | 12.8× | 128.1× | 22.3× | 13.8× | 0.0% | |
| MGNXMacroGenics, Inc. | 217.85M | −8.1% | −2.3× | — | — | 1.2× | 5.1× | −2.5× | 0.5× | 0.0% | |
| Peer median | 1.75B | −4.8% | 17.1× | — | — | 12.8× | 4.3× | 28.1× | 12.4× | 0.0% |
Positioning
Bubble size is market cap. A name above the cluster costs more for the same growth or margin.